M. Spengler

1.0k total citations
27 papers, 755 citations indexed

About

M. Spengler is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, M. Spengler has authored 27 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in M. Spengler's work include Pharmacology and Obesity Treatment (9 papers), Blood properties and coagulation (5 papers) and Erythrocyte Function and Pathophysiology (5 papers). M. Spengler is often cited by papers focused on Pharmacology and Obesity Treatment (9 papers), Blood properties and coagulation (5 papers) and Erythrocyte Function and Pathophysiology (5 papers). M. Spengler collaborates with scholars based in Germany, Argentina and United States. M. Spengler's co-authors include Juergen Hoffmann, Jürgen Hoffmann, M Hanefeld, Sabine Fischer, Manfred Wargenau, K. Fücker, Jan Schulze, K. Boehme, W Scheppach and Frank Ahrens and has published in prestigious journals such as Gastroenterology, Diabetes Care and The American Journal of Medicine.

In The Last Decade

M. Spengler

25 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Spengler Germany 15 501 185 164 130 121 27 755
Ümit Karayalçın Türkiye 15 299 0.6× 98 0.5× 45 0.3× 109 0.8× 136 1.1× 33 646
Mingrui Xiong China 17 180 0.4× 361 2.0× 65 0.4× 60 0.5× 128 1.1× 28 891
Valentina Spigoni Italy 17 156 0.3× 188 1.0× 63 0.4× 108 0.8× 87 0.7× 25 582
M. Dominique Ashen United States 13 156 0.3× 147 0.8× 43 0.3× 76 0.6× 138 1.1× 23 628
Benli Su China 12 380 0.8× 307 1.7× 42 0.3× 249 1.9× 119 1.0× 31 808
D. Petzinna Germany 11 220 0.4× 99 0.5× 61 0.4× 38 0.3× 150 1.2× 14 498
A Vrána Czechia 16 323 0.6× 242 1.3× 30 0.2× 318 2.4× 107 0.9× 48 724
C. Thevenon France 13 111 0.2× 113 0.6× 57 0.3× 119 0.9× 152 1.3× 17 634
Alfredo Quiñones-Galvan Italy 11 117 0.2× 127 0.7× 40 0.2× 180 1.4× 114 0.9× 15 535
Laura McCreight United Kingdom 4 264 0.5× 383 2.1× 38 0.2× 158 1.2× 158 1.3× 8 617

Countries citing papers authored by M. Spengler

Since Specialization
Citations

This map shows the geographic impact of M. Spengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Spengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Spengler more than expected).

Fields of papers citing papers by M. Spengler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Spengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Spengler. The network helps show where M. Spengler may publish in the future.

Co-authorship network of co-authors of M. Spengler

This figure shows the co-authorship network connecting the top 25 collaborators of M. Spengler. A scholar is included among the top collaborators of M. Spengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Spengler. M. Spengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Spengler, M., et al.. (2011). Erythrocyte aggregation in patients with systemic lupus erythematosus. Clinical Hemorheology and Microcirculation. 47(4). 279–285. 26 indexed citations
3.
Spengler, M., et al.. (2011). Effects of ascorbate fatty ester derivatives on erythrocyte membrane lipoperoxidation. Clinical Hemorheology and Microcirculation. 47(3). 163–168. 7 indexed citations
4.
Spengler, M., et al.. (2008). Study on membrane fluidity and erythrocyte aggregation in equine, bovine and human species.. PubMed. 38(3). 171–6. 14 indexed citations
5.
Spengler, M., et al.. (2007). Nifedipine effect on red cell rheological properties in patients with systemic scleroderma.. PubMed. 36(2). 105–10. 5 indexed citations
6.
Spengler, M., et al.. (2007). Effect of ascorbic acid based amphiphiles on human erythrocytes membrane.. PubMed. 36(2). 133–40. 14 indexed citations
7.
Segal, P, et al.. (2005). Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 25(9). 589–595. 12 indexed citations
8.
Spengler, M., et al.. (2005). Evaluation of the Efficacy and Tolerability of Acarbose in Patients??with Diabetes Mellitus. Clinical Drug Investigation. 25(10). 651–659. 21 indexed citations
9.
Spengler, M., et al.. (2004). Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.. PubMed. 30(1). 17–24. 16 indexed citations
10.
Spengler, M., et al.. (2003). Effect of hormone replacement therapy upon haemorheological variables.. Zaguan (University of Zaragoza Repository). 28(1). 13–9. 10 indexed citations
11.
Spengler, M., et al.. (2001). Influence of Plasma Proteins on Erythrocyte Aggregation in Three Mammalian Species. Veterinary Research Communications. 25(7). 591–599. 5 indexed citations
12.
Lindström, Jaana, et al.. (2000). Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. Diabetic Medicine. 17(1). 20–25. 15 indexed citations
13.
Kentrup, H., H. Bongers, M. Spengler, G. Kusenbach, & H. Skopnik. (1999). Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. European Journal of Pediatrics. 158(6). 455–459. 19 indexed citations
14.
Fischer, Sabine, M Hanefeld, M. Spengler, K. Boehme, & Theodora Temelkova‐Kurktschiev. (1998). European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses. Acta Diabetologica. 35(1). 34–40. 51 indexed citations
15.
Hoffmann, Jürgen & M. Spengler. (1997). Efficacy of 24-Week Monotherapy With Acarbose, Metformin, or Placebo in Dietary-Treated NIDDM Patients. The American Journal of Medicine. 103(6). 483–490. 120 indexed citations
16.
Ḧopfner, M., et al.. (1997). Effect of acarbose and simultaneous antacid therapy on blood glucose.. PubMed. 47(10). 1108–11. 1 indexed citations
17.
Spengler, M., et al.. (1992). Ösophagobronchiale Fistel - Zufallsbefund bei Bariumbreischluck. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 157(10). 425–426. 1 indexed citations
18.
Spengler, M., Gisele Hansel, & K. Boehme. (1992). Efficacy of 6 months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM).. PubMed. 26. 50–1. 11 indexed citations
19.
Scheppach, W, et al.. (1988). Effect of Starch Malabsorption on Colonic Function and Metabolism in Humans. Gastroenterology. 95(6). 1549–1555. 61 indexed citations
20.
Thiébaud, D., E Jacot, H. Schmitz, M. Spengler, & J. P. Felber. (1984). Comparative study of isomalt and sucrose by means of continuous indirect calorimetry. Metabolism. 33(9). 808–813. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ümit Karayalçın Breakdown of academic impact, for papers by Mingrui Xiong Breakdown of academic impact, for papers by Valentina Spigoni Breakdown of academic impact, for papers by M. Dominique Ashen Breakdown of academic impact, for papers by Benli Su Breakdown of academic impact, for papers by D. Petzinna Breakdown of academic impact, for papers by A Vrána Breakdown of academic impact, for papers by C. Thevenon Breakdown of academic impact, for papers by Alfredo Quiñones-Galvan Breakdown of academic impact, for papers by Laura McCreight
Rankless by CCL
2026